University Children's Hospital Tuebingen
- Country
- 🇩🇪Germany
- Ownership
- Private
- Employees
- -
- Market Cap
- -
Clinical Trials
6
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALL
- Conditions
- Primary/Relapsed Acute Lymphoblastic Leukemia (ALL) of Childhood, Adolescents and Young Adults
- First Posted Date
- 2018-06-18
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- University Children's Hospital Tuebingen
- Target Recruit Count
- 30
- Registration Number
- NCT03559413
- Locations
- 🇩🇪
University Medical Center for Children and Adolescents Heidelberg, Heidelberg, Baden-Württemberg, Germany
🇩🇪University Children's Hospital Tübingen, Tübingen, Baden-Württemberg, Germany
🇩🇪University Children's Hospital Munich, Center for Pediatric Hematology and Oncology, München, Bayern, Germany
CH14.18 1021 Antibody and IL2 After Haplo SCT in Children With Relapsed Neuroblastoma
- First Posted Date
- 2014-10-07
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- University Children's Hospital Tuebingen
- Target Recruit Count
- 35
- Registration Number
- NCT02258815
- Locations
- 🇦🇹
University Hospital Graz, Graz, Austria
🇦🇹St. Anna Childrens Hospital, Vienna, Austria
🇩🇪University Hospital Greifswald, Greifswald, Germany
Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells
- Conditions
- Aplastic AnemiaAcute LeukemiasChildhood Solid Tumor
- First Posted Date
- 2013-08-09
- Last Posted Date
- 2014-10-08
- Lead Sponsor
- University Children's Hospital Tuebingen
- Target Recruit Count
- 120
- Registration Number
- NCT01919866
- Locations
- 🇩🇪
University Children's Hospital, Tuebingen, Germany
🇩🇪Medizinische Hochschule Zentrum für Kinderheilkunde, Hannover, Germany
Anti-inflammatory Pulmonal Therapy of Cystic Fibrosis (CF) Patients With Amitriptyline and Placebo
- First Posted Date
- 2011-03-07
- Last Posted Date
- 2011-03-07
- Lead Sponsor
- University Children's Hospital Tuebingen
- Target Recruit Count
- 30
- Registration Number
- NCT01309178
- Locations
- 🇩🇪
Lutz Naehrlich, Giessen, Germany
🇩🇪Jochen Mainz, Jena, Germany
🇩🇪Joachim Riethmueller, Tuebingen, Germany
Antimycotic Prophylaxis in Pediatric Patients Following Allogeneic Stem Cell Transplantation
- Conditions
- Systemic AspergillosisSystemic Candidiasis
- First Posted Date
- 2009-12-29
- Last Posted Date
- 2009-12-29
- Lead Sponsor
- University Children's Hospital Tuebingen
- Registration Number
- NCT01040156
- Locations
- 🇩🇪
University Children's Hospital, Tuebingen, Germany
- Prev
- 1
- 2
- Next